Clinical utility of 188Rhenium-hydroxyethylidene-1,1-diphosphonate as a bone pain palliative in multiple malignancies

Clinical utility of 188Rhenium-hydroxyethylidene-1,1-diphosphonate as a bone pain palliative in multiple malignancies

188Rhenium-hydroxyethylidene-1,1-diphosphonate (188Re-HEDP) is a clinically established radiopharmaceutical for bone pain palliation of patients with metastatic bone cancer. Herein, the effectiveness of 188Re-HEDP for the palliation of painful bone metastases was investigated in an uncontrolled init...

Full description

Bibliographic Details
Main Authors: Ajit S Shinto, Madhava B Mallia, Mythili Kameswaran, K K Kamaleshwaran, Jephy Joseph, E R Radhakrishnan, Indira V Upadhyay, R Subramaniam, Madhu Sairam, Sharmila Banerjee, Ashutosh Dash
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:World Journal of Nuclear Medicine
Subjects:
Bone metastasis
hydroxyethylidene-1
1-diphosphonate
pain palliation
radionuclide therapy
rhenium-188
Online Access:http://www.wjnm.org/article.asp?issn=1450-1147;year=2018;volume=17;issue=4;spage=228;epage=235;aulast=Shinto

Internet

http://www.wjnm.org/article.asp?issn=1450-1147;year=2018;volume=17;issue=4;spage=228;epage=235;aulast=Shinto

Similar Items